Clinical trial
National Retrospective Monitoring of Patients With Acute Leukemia Infected by COronaVirus Disease 2019 (COVID-19)
NCT04452604 is registered in ClinicalTrials.gov with French Innovative Leukemia Organisation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- National Retrospective Monitoring of Patients With Acute Leukemia Infected by COronaVirus Disease 2019 (COVID-19)
- Lead sponsor
- French Innovative Leukemia Organisation
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 11, 2020
- Completion date
- July 7, 2021
- Enrollment
- 79 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, acute myeloblastic leukemia, sars-cov-2